Arthur Suckow is the founder of DTx Pharma. DTx Pharma has raised $114M in total funding. Latest round: Series B. Based in San Diego, United States.
Arthur Suckow is a co-founder of DTx Pharma, a San Diego-based biotechnology company established in 2017. The company develops RNA therapeutics using its proprietary FALCON platform to address unmet medical needs in rare conditions. DTx Pharma successfully raised over $114 million in venture capital, including a $100 million Series B financing, before being acquired by Novartis for $1 billion.
Full founder directory · Investor directory · Company funding database · Fundraising library